Expanded Access Research Program



					En español

The information you provide will be available to PAREXEL International,LLC ("PAREXEL") to provide the information and services you request. Personal information about you will not otherwise be disclosed for marketing purposes without your permission. PAREXEL reviews personal information and nonidentifiable information not only to provide therequested information and services but also to develop and offer additional services and communications that we believe our customers might find of interest. PAREXEL also may use personal information to audit its resources for compliance and security purposes.

For more information, please visit www.parexel.com.

Recruitment for EARMRK in the Bahamas, Finland, Germany, Ireland, Italy, Netherlands, Ontario, Puerto Rico, Spain, Sweden and USA is now closed as MK-0518 (ISENTRESS™ (raltegravir)) has been approved.





Country *

Title *

Physician Name *

Physician Family Name *

Address 1 *

Address 2

Address 3

City *

State/Province

Zip Code/Postal Code *

Telephone *

Fax Number

E-mail *

Do you have a current patient that may be eligible for the study?
		Yes No




* indicates a Required Field